Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Long-Term Deferred Tax (2016)

Apyx Medical (APYX) has disclosed Long-Term Deferred Tax for 7 consecutive years, with $21000.0 as the latest value for Q2 2016.

  • For the quarter ending Q2 2016, Long-Term Deferred Tax changed N/A year-over-year to $21000.0, compared with a TTM value of $21000.0 through Jun 2016, changed N/A, and an annual FY2015 reading of $25000.0, up 104.43% over the prior year.
  • Long-Term Deferred Tax was $21000.0 for Q2 2016 at Apyx Medical, down from $39000.0 in the prior quarter.
  • Across five years, Long-Term Deferred Tax topped out at $5.3 million in Q3 2014 and bottomed at -$564000.0 in Q4 2014.
  • Average Long-Term Deferred Tax over 5 years is $1.5 million, with a median of $1.4 million recorded in 2012.
  • The sharpest move saw Long-Term Deferred Tax tumbled 116.53% in 2014, then surged 104.43% in 2015.
  • Year by year, Long-Term Deferred Tax stood at $2.5 million in 2012, then skyrocketed by 35.5% to $3.4 million in 2013, then crashed by 116.53% to -$564000.0 in 2014, then skyrocketed by 104.43% to $25000.0 in 2015, then decreased by 16.0% to $21000.0 in 2016.
  • Business Quant data shows Long-Term Deferred Tax for APYX at $21000.0 in Q2 2016, $39000.0 in Q1 2016, and $25000.0 in Q4 2015.